This image of an enormous ship under construction features in a new book and show that challenge common ideas about beauty – while the real ship may help cut carbon emissions
Read More
https://www.newscientist.com/article/mg24532732-800-peer-into-a-giant-half-formed-ship-that-can-hold-18000-containers/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=home
Views: 0
Tips to help you avoid common 529 plan withdrawal mistakes.
Read More
https://investornews.vanguard/planning-to-make-a-529-withdrawal-learn-how-to-steer-clear-of-common-mistakes/
Views: 0
France’s highest court has ruled that many common crops are illegal because they contain genetic mutations, but enforcing the law will be near impossible
Read More
https://www.newscientist.com/article/mg24532742-800-many-plants-may-soon-be-illegal-in-france-and-no-one-knows-what-to-do/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=home
Views: 0
JOHOR BARU: A special working committee will be set up to formulate mitigation plan to address the issues of the movement of people, goods and services between Malaysia and Singapore, said Johor Mentri Besar Datuk Hasni Mohammad (pix).
He said following the latest development of the Covid-19 outbreak and the announcement of the Movement Control Order yesterday, Prime Minister Tan Sri Muhyiddin Yassin today agreed that the committee be set up.
“The committee will be jointly-chaired by Senior Minister of Defence Datuk Seri Ismail Sabri Yaakob, myself and a Singaporean cabinet representative,” he said in a statement today.
He said the committee would be tasked with formulating mitigation plan for managing common interests between Malaysia and Singapore, particularly in ensuring the smooth and safe movement of Malaysians working in Singapore.
Hasni said the committee would then present recommendations to the prime minister of both countries for further action.
He said the committee also would notify the progress of related issues from time to time. – Bernama
Read More
https://www.thesundaily.my/local/malaysia-singapore-working-committee-to-be-set-up-following-movement-control-order-BC2141614
Views: 0
There may be two different categories of type 1 diabetes that are more common at different ages. Understanding the differences could lead to new treatments
Read More
https://www.newscientist.com/article/2237221-type-1-diabetes-may-be-two-conditions-that-need-different-treatments/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=home
Views: 0
Genetic analysis suggests all Arabica coffee plants are descended from a single common ancestor, and this lack of genetic diversity makes them vulnerable to extinction
Read More
https://www.newscientist.com/article/2237296-every-arabica-coffee-plant-may-come-from-a-single-common-ancestor/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=home
Views: 0
Vanguard highlights common investor missteps amid market downturns.
Read More
https://investornews.vanguard/3-mistakes-to-avoid-during-a-market-downturn/
Views: 0
Working from home is already so common it has its own acronym, and it’s about to get even more common still. Companies like Apple, Amazon and Microsoft are now advising employees to “WFH” to avoid exposure to the novel coronavirus.
Read More
Views: 0
This Medical Product Alert relates to a series of confirmed falsified antimalarials circulating in West and Central Africa. Medicines subject of this alert display a similar logo to the outdated
WHO Essential Drugs Programme logo.
Since 2013, different falsified medicines, all displaying the outdated WHO Essential Drugs Programme logo, have been reported to the WHO Global Surveillance and Monitoring System by various stakeholders. The continued and widespread availability of these falsified medicines highlights a strong need for additional vigilance. WHO previously published two alerts on this issue (No.132 in Oct 2014, and No.131 in March 2014)
This WHO medical product alert N°1/2020 refers to falsified Quinine Sulphate 300mg presented in six different combinations of batch numbers, expiry and manufacturing dates (see Table 1). The fraudulent use of the outdated WHO Essential Drugs Programme logo may create a false sense of product quality.
Table 1: List of identified falsified Quinine Sulphate 300mg, subject of WHO Alert N°1/2020
Recently received results of analysed samples show they do not contain any of the expected active ingredients.
Quinine sulphate is referenced on the WHO Model List of Essential Medicines, to manage and treat severe malaria. At this stage, no adverse reactions attributed to these falsified products have been reported to WHO.
All the above falsified products claim to be manufactured by REMEDICA LTD – Cyprus and to contain 300mg of quinine sulphate. Remedica Ltd has confirmed that:
These falsified medicines display the following common characteristics (please see photographs):
Product details, photographs and advice to the public are available on the following pages.
1. Falsified
Quinine Sulphate Tablets B.P 300mg identified
in Chad (Batch 44680)
WHO requests increased vigilance within the supply chains of countries likely to be affected by these falsified products. Increased vigilance should include hospitals, clinics, health centres, wholesalers, distributors, pharmacies and any other suppliers of medical products.
If you are in possession of the above products, please do not use. If you have used these falsified products, or if you suffer an adverse event having used these products, please seek immediate advice from a qualified healthcare professional, and ensure they report the incident to your local Ministry of Health/National Medicines Regulatory Authorities/National Pharmacovigilance Centre.
All medical products must be obtained from authentic and reliable sources. Their authenticity and condition should be carefully checked. Seek advice from a healthcare professional in case of doubt.
National health authorities are asked to immediately notify WHO if these falsified products are discovered in their country. If you have any information concerning the manufacture, distribution, or supply of these products, please contact rapidalert@who.int .
For further information, please visit our website: www.who.int/medicines/regulation/ssffc/en/
Read More
https://www.who.int/news-room/detail/09-03-2020-medical-product-alert-n-1-2020-english-version
Views: 0
A team of researchers from NUS have invented a novel class of reconfiguration techniques that adaptively extends both the minimum power consumption and the maximum performance of digital circuits, well beyond common voltage scaling. Such extended adaptation allows digital silicon chips to operate at lower power during normal use, and at higher performance level when necessary.
Read More
Views: 0